Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 6/20 | 0.36 |
| ▸ | PPARA | Q07869 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23971575 | 0.94 | HIF1A (0.59) | HIF1ARAB9ANPC1PPARGPPARA | |
| SCHEMBL23971878 | 0.92 | HIF1A (0.54) | HIF1ARAB9ANPC1PPARGPPARA | |
| SCHEMBL23971689 | 0.90 | HIF1A (0.54) | HIF1ARAB9ANPC1PPARGPPARA | |
| SCHEMBL23972048 | 0.90 | HIF1A (0.52) | HIF1AKDM4ERAB9ANPC1POLB | |
| SCHEMBL23972078 | 0.90 | HIF1A (0.43) | HIF1AKDM4EGAAMAPTRAB9A | |
| SCHEMBL25601226 | 0.90 | HIF1A (0.55) | HIF1ARAB9ANPC1PPARGPPARA | |
| SCHEMBL23971717 | 0.90 | HIF1A (0.52) | HIF1AMAPTRAB9ANPC1PPARG | |
| SCHEMBL23971810 | 0.90 | HIF1A (0.60) | HIF1AKDM4EGAAMAPTRAB9A | |
| SCHEMBL23971829 | 0.90 | HIF1A (0.52) | HIF1AGAAMAPTRAB9ANPC1 | |
| SCHEMBL23971758 | 0.90 | HIF1A (0.52) | HIF1AMAPTRAB9ANPC1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021219388-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS III | BASF SE (DE) | 2021-11-04 | — | — | WO | disclosed |
| WO-2021219390-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS IV | BASF SE (DE) | 2021-11-04 | — | — | WO | disclosed |
| WO-2021219386-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS I | BASF SE (DE) | 2021-11-04 | — | — | WO | disclosed |